Even in the US, infectious diseases are the third most common cause of death, despite the widespread availability of antibiotics, vaccines, and advanced hygienic standards. The identification of new pathogens, the re-emergence of old pathogens, and the increasing incidence of antibiotic resistance reflect the globalization of humanity and microbes. As illustrated by the recent anthrax, SARS, and monkeypox outbreaks, new as well as old pathogens can be rapidly moved great distances and establish footholds in new niches. Strategies for the prevention, treatment, and control of infectious diseases will require fundamental bench research that takes advantages of rapid advances in genomics, proteomics, cell biology, and immunology to develop new diagnostics, therapeutics, and vaccines. The study of microbial pathogenesis is a rapidly advancing area of research, with unprecedented opportunity to influence health worldwide. Over the past 5 years, UCSF has created a strong training environment and established an outstanding program in Infectious Disease and Host Defense. There are 26 faculty already associated with the program and several new hires planned; space and resources to recruit 2-3 more faculty have been allocated; a course, journal club and research talks are now offered, and a yearly symposium established. This new T32 grant application describes the new program at UCSF in Microbial Pathogenesis and Host Defense that will train the next generation of scientists who can combat disease through advances in basic and translational research. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI060537-05
Application #
7440300
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
2004-08-01
Project End
2009-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$257,423
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Binning, Jennifer M; Smith, Amber M; Hultquist, Judd F et al. (2018) Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. PLoS Pathog 14:e1006830
Shenoy, Meera K; Lynch, Susan V (2018) Role of the lung microbiome in HIV pathogenesis. Curr Opin HIV AIDS 13:45-52
Dolan, Patrick T; Whitfield, Zachary J; Andino, Raul (2018) Mapping the Evolutionary Potential of RNA Viruses. Cell Host Microbe 23:435-446
Dornfeld, Dominik; Dudek, Alexandra H; Vausselin, Thibaut et al. (2018) SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses. Sci Rep 8:2092
Cornejo, Elias; Schlaermann, Philipp; Mukherjee, Shaeri (2017) How to rewire the host cell: A home improvement guide for intracellular bacteria. J Cell Biol 216:3931-3948
Faust, Tyler B; Binning, Jennifer M; Gross, John D et al. (2017) Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription. Annu Rev Virol 4:241-260
Jensen, Helle; Potempa, Marc; Gotthardt, Dagmar et al. (2017) Cutting Edge: IL-2-Induced Expression of the Amino Acid Transporters SLC1A5 and CD98 Is a Prerequisite for NKG2D-Mediated Activation of Human NK Cells. J Immunol 199:1967-1972
Ruch, Travis R; Engel, Joanne N (2017) Targeting the Mucosal Barrier: How Pathogens Modulate the Cellular Polarity Network. Cold Spring Harb Perspect Biol 9:
Shenoy, Meera K; Iwai, Shoko; Lin, Din L et al. (2017) Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia. Am J Respir Crit Care Med 195:104-114
English, Bevin C; Van Prooyen, Nancy; Örd, Tiit et al. (2017) The transcription factor CHOP, an effector of the integrated stress response, is required for host sensitivity to the fungal intracellular pathogen Histoplasma capsulatum. PLoS Pathog 13:e1006589

Showing the most recent 10 out of 107 publications